The suitably functionalized cyclopentanone derivatives 12, 13, 19, and 37 serve as common precursors for the synthesis of various prostaglandins, prostaglandin-1,15-lactones, and unnatural analogues thereof. All of them contain a 2-butynyl entity which is elaborated into the intact R side chain of the targets either via a sequence comprising ring closing alkyne metathesis/Lindlar reduction or via alkyne cross metathesis (ACM)/ Lindlar reduction. These novel approaches are distinguished by (i) the ready accessibility of the required cyclopentenone substrates via a three-component coupling reaction, (ii) the inherent flexibility which allows one to make a series of analogues starting from these common platforms, (iii) a small number of steps, and (iv) an excellent overall yield. The key alkyne metathesis reactions are efficiently catalyzed either by the tungsten alkylidyne complex (t-BuO) 3 WtCCMe 3 or, preferentially, by a catalyst formed in situ from Mo-[N(t-Bu)(Ar)] 3 and CH 2 Cl 2 , the reactivity of which can be fine-tuned by varying the Ar substituent on the amido ligands. These organometallic tools exhibit a remarkable application profile, tolerate an array of polar groups, rigorously distinguish between different π-electron systems, and catalyze the reactions under conditions that are sufficiently mild to preserve even highly sensitive functionalities. The structures of the macrocyclic prostaglandin lactone derivatives 22 and 32 were characterized by X-ray crystallography.
Introduction
Prostaglandins (PG's) are signaling compounds of tremendous importance in mammals and many other animals controlling biological functions as diverse as smooth muscle contraction, platelet aggregation, broncial and vascuolar constriction, chemotaxis, ion secretion (stomach acidity), reproduction, immune responses, and neuro-endocrinal processes, just to mention the most important effects. 1 Due to their exceptional potency in vivo, only minute amounts of PG's are present in the organism; in general, these secondary metabolites are biosynthesized de novo from arachidonic acid as the common precursor following chemical, immunological, or mechanical stimulation and are metabolized immediately after eliciting the respective biological response. 1 In view of this well-established mode of action as local tissue hormones that are formed "on demand" and "on site", it was most surprising to find that the marine nudibranch Tethys fimbria produces fairly large amounts of prostaglandin-1,15-lactones such as 1-3 and accumulates them in the cerata (dorsal appendages) and ovotestis. 2, 3 This is the only example for an in ViVo storage of PG's reported in the literature. These molluscs seem to have developed a rather sophisticated and economical way of exploiting these unusual metabolites for more than one purpose. 2 Specifically, 1-3 are present in high concentrations in the mucous secretion that is immediately released on mechanical molestation. In view of their ichtyotoxic properties (activity against the mosquito fish Gambusia affinis at concentrations of 1-10 µg/mL), the lactones themselves play an important role in the chemical defense mechanism of T. fimbria against potential predators. Moreover, hydrolytic enzymes Chem. 1983, 95, 854; Angew. Chem., Int. Ed. Engl. 1983, 22, 805. (f) Bergström, S. Angew. Chem. 1983, 95, 865; Angew. Chem., Int. Ed. Engl. 1983, 22, 858. (g) Vane, J. R. Angew. Chem., Int. Ed. Engl. 1983, 22, 741. (h) Horton, E. W. Chem. Soc. ReV. 1975, 4, 589. (i) Ramwell, P. W.; Shaw, J. E.; Corey, E. J.; Andersen, N. Nature 1969, 221, 1251.
(2) (a) Cimino, G.; Crispino, A.; Di Marzo, V.; Sodano, G.; Spinella, A.; Villani, G. Experientia 1991, 47, 56. (b) Cimino, G.; Spinella, A.; Sodano, G. Tetrahedron Lett. 1989, 30, 3589. (c) Cimino, G.; Crispino, A.; Di Marzo, V.; Spinella, A.; Sodano, G. J. Org. Chem. 1991 , 56, 2907 Di Marzo, V.; Cimino, G. Marine Biol. 1991, 111, 353. ( Cimino, G.; Crispino, A.; Minardi, C.; Sodano, G.; Spinella, A. Biochem. J. 1991, 273, 593. (3) See the following for a comprehensive review on prostanoids of marine origin: Gerwick, W. H. Chem. ReV. 1993 ReV. , 93, 1807 readily convert them into the parent prostaglandins (e.g. 1 f 4) which are then used to control smooth muscle contractions of the cerata extruding the defense secretion. Finally, fatty acid esters of 3 likely serve as chemical release factors for ovulation and therefore exert important functions in the reproduction of these animals. 2 PG-1,15-lactones have also caught the attention of medicinal chemists. 4 The widespread use of prostaglandin esters as prodrugs suggests that these intramolecular versions may serve similar purposes. Since their polarities and shapes are considerably different from those of the uncyclized hydroxy acids, they may go unrecognized by normal PG processing enzymes; depending on the different esterase activity in various tissues, however, one may envisage a localized release of the parent prostaglandin and thereby trigger a sustained onset of its specific biological function. 5 Intrigued by these diverse and promising physiological and pharmacological properties, we have engaged in a program aimed at the total synthesis of this class of natural products. 6 Described below is a comprehensive summary of our results in this field which led to the total synthesis of prostaglandin E 2 -1,15-lactone (1), 15-epi-prostaglandin E 2 -1,15-lactone (22), and the parent prostaglandin E 2 (4) itself, as well as to a formal total synthesis of prostaglandin A 2 -1,15-lactone (2). Although 1 can also be prepared from PGE 2 4 by macrolactonization reactions, 7 we believe that the use of alkyne metathesis as a fundamentally different and novel concept for the construction of such target molecules offers significant advantages, including a high overall efficiency, an excellent "economy of steps", 8 and an inherent flexibility in structural terms. The latter aspect is illustrated by the synthesis of several previously unknown PG analogues differing from the natural product in the R side chain which is particularly difficult to alter and manipulate by more conventional approaches.
Results and Discussion
Strategy. Ring closing metathesis of dienes (RCM) has recently gained considerable importance as a tool for organic synthesis. 9, 10 Among the few shortcomings that infringe upon the superb overall application profile of RCM, the lack of control over the configuration of the newly formed double bond is most noteworthy if the reaction is applied to the macrocyclic series. The products formed are usually obtained as mixtures of the (E)-and (Z)-isomers, with the former dominating in most of the recorded cases. 9, 10 This tendency to form product mixtures constitutes an obvious drawback in target-oriented synthesis.
To circumwent this inherent problem, we have proposed an indirect but stereoselectiVe approach to macrocyclic (Z)-alkenes which consists of a ring-closing metathesis of diyne substrates followed by Lindlar reduction of the resulting cycloalkyne products (Scheme 1). 11-14 Three different catalyst systems have been used so far for this purpose, including (1) the tungsten alkylidyne complex (t-BuO) 3 WtCCMe 3 developed by Schrock, 15 (2) a structurally unknown catalyst formed in situ from Mo(CO) 6 and p-chlorophenol (or related phenol additives), 16 and (3) Mo[N(t-Bu)(Ar)] 3 5 or 6 activated in situ by means of CH 2 Cl 2 . 13, 17 Although all previous applications of these tools are very promising, [11] [12] [13] [14] 18 alkyne metathesis in general is still in its infancy as compared with alkene metathesis and the envisaged extension of this methodology to a total synthesis of 1 and related targets therefore raises several new questions: Thus, it was not clear at the beginning of this investigation if the rather electrophilic ketone group of 1 will survive alkyne metathesis or if lengthy protecting group manipulations are required; this aspect deserves particular consideration since tungsten alkylidynes are known to be sufficiently nucleophilic to react, e.g., with acetone and related carbonyl compounds in a Wittig-type process. 19 The reactivity of the other alkyne metathesis catalysts mentioned above toward ketones has not been studied at all. Moreover, the aldol substructure of PGE 2 is known to be quite labile toward acid as well as base, 20 thus rendering the envisaged cyclization of the macrocyclic ring at the ∆ 5,6 -bond (Scheme 2) a stringent test for the mildness of the method. Finally, it should be noted that the catalyst has to distinguish between the alkyne groups and the preexisting (E)-alkene in the cyclization precursor to be useful in this preparative context.
Total Synthesis of (-)-Prostaglandin E 2 -1,15-Lactone. Despite these issues, we have engaged in the total synthesis of (-)-1 summarized in Scheme 3. "Three-component coupling" 21 as the most elegant method for the construction of prostaglandin skeletons efficiently provides the required cyclization precursor 15. Thus, commercially available propargyl alcohol 7 (ee 98%) is protected as a triethylsilyl (TES) ether prior to conversion into vinylstannane 8 under free radical conditions. 22 Tin for lithium exchange on exposure of compound 8 to n-BuLi at low temperature followed by addition of Me 2 Zn affords a zincate intermediate that undergoes smooth conjugate addition to the known Michael acceptor 9 (ee 94%). 23 Enolate 10 thus formed is quenched with propargyl iodide 11 24 to afford adduct 12. 25 Selective deprotection of the TES group of the crude material with dilute HOAc in aqueous THF delivers compound 13 in diastereomerically and enantiomerically pure form in 74% yield over both steps (ee g99%). 26a This excellent result reflects the high reactivity of 11 as the electrophile in this three-component assembly (vide infra). Subsequent esterification of the free -OH group of 13 with 5-heptynoic acid 14 24b in the presence of diisopropyl carbodiimide and catalytic amounts of DMAP readily provides diyne 15 and sets the stage for the crucial macrocyclization via ring-closing alkyne metathesis.
Gratifyingly, this key transformation performs very well using the catalyst formed in situ from Mo[N(t-Bu)(Ar)] 3 (Ar ) 3,5-dimethylphenyl) 5 and CH 2 Cl 2 in toluene at 80°C, 13 affording (19) (RO)3WtCCMe3 (R ) 2,6-diisopropylphenyl) reacts rapidly with acetone, benzaldehyde, paraformaldehyde, ethyl formate, DMF, and acetonitrile in Wittig-like reactions, cf.: Freudenberger, J. H.; Schrock, R. R. Organometallics 1986, 5, 398.
(20) (a) Outside of the pH range of ca. 5-8, E-type prostaglandins suffer facile dehydration to give compounds of the A series which further isomerize when exposed to base, cf.: Andersen, N. H. J. Lip. Res. 1969, 10, 320. (b) This intrinsic lability consitutes a severe preparative constraint that has to be taken into account in all routes to these targets. (21) See the following for pertinent reviews on "three-component coupling": (a) Noyori, R.; Suzuki, M. Angew. Chem. 1984, 96, 854; Angew. Chem., Int. Ed. Engl. 1984, 23, 847. (b) 1978, 43, 3450 . This paper pretends that the hydrostannylation of the TESether of alcohol 7 is regio-and diastereoselective according to 13 C NMR data. Careful analysis of the crude product by HPLC, however, shows that the purity is only ca. 90%. This material can be used directly in the next step, because the isomeric byproducts do not undergo productive 1,4-addition, cf.: Johnson, C. R.; Penning, T. D. J. Am. Chem. Soc. 1988, 110, 4726. ( 
Scheme 2
Scheme 3 the desired cycloalkyne 16 in 68-73% isolated yield (4 runs). The modified catalyst 6 in which the 3,5-dimethylphenyl group on the amido ligands is replaced by a 4-fluorophenyl residue 27 gives an even higher yield (77%). Careful chromatographic inspection of the reaction mixture reveals that no racemization takes place before or after ring closure and that the ee values of the substrate (ee 99%) 26a and of the product (ee 98%) 26b are also virtually identical. This example highlights the excellent overall application profile of this type of catalyst which is very reactive toward alkynes but highly tolerant with an array of polar functional groups (cf. Table 3 ). The transformation occurs under exceptionally mild conditions allowing one to preserve very labile structural elements and guaranteeing the integrity of chiral centers even if positioned R to a carbonyl group. Although the precise mode of action of 5 still constitutes a subject of ongoing investigations, 27 it is remarkable that this species rigorously distinguishes between different π-systems, since it selects exclusively for triple bonds (reactive) whereas preexisting double bonds in the substrate are inert.
Standard Lindlar hydrogenation of cycloalkyne 16 thus formed followed by deprotection of the residual TBS ether with aqueous HF in acetonitrile 28 completes this total synthesis of the marine natural product (-)-prostaglandin E 2 -1,15-lactone 1 which is obtained in respectable 28% overall yield. Its 600 MHz NMR spectra are in full agreement with the data reported in the literature (for details see the Experimental Section). 2 By virtue of the known enzymatic hydrolysis of this compound into prostaglandin E 2 4 as well as by the known transformation of 1 into PGA 2 -1,15-lactone 2, 4 formal total syntheses of these interesting natural products have also been accomplished (vide infra for an alternative approach to PGE 2 ).
Finally it should be mentioned that the order of Lindlar reduction and deprotection can also be inverted (Scheme 4). Thus, cycloalkyne 16 can first be deprotected to afford free alcohol 18 which constitutes an acetylenic congener of 1. Biological studies of this and other analogues (see below) prepared during this study are underway. Lindlar reduction then completes a second route to 1. Given the usefulness of derivatives with a triple bond at the 5,6-position in the R-chain as common intermediates for the preparation of various natural and unnatural PG's, most notably of prostacyclin and derivatives thereof, 29 product 16 also opens many possibilities for further transformations which are presently pursued in this laboratory.
Catalyst Optimization: 15-epi-Prostaglandin E 2 -1,15-Lactone. Having in mind that the configuration at C-15 is a critical determinant for PG-receptor affinity and specificity, 1 we have prepared the 15-epi-congener of 1, i.e., lactone 22 (Scheme 5), by following a route similar to the one outlined above. 30 The crucial cyclization of diyne 19 to cycloalkyne 20 was also taken as an opportunity to compare the performance of different alkyne metathesis catalysts to gain a better understanding of their specific application profiles in sensitive cases. The results are compiled in Table 1 and deserve some comments.
In line with our expectations, the catalyst formed in situ from 5 and CH 2 Cl 2 gave excellent results (entry 1). 13 TLC control shows a smooth and quantitative spot-to-spot conversion of the substrate into the desired product, which is obtained in 81% isolated yield. It is also interesting to note that the reactivity of the catalyst can be tuned to some extend by changing the electronic properties of its amido ligands. Thus, catalyst 6 in which the Ar ) 3,5-dimethylphenyl substituents originally (30) Three-component coupling of racemic 8, 9, and 11 followed by deprotection of the TES group provided a ca. 1:1 mixture of (()-13 and (()-epi-13. These compounds can be easily separated by flash chromatography. Esterification of (()-epi-13 with 5-heptynoic acid afforded (()-19, which was employed in this study. For details see the Supporting Information. (27) furan (11, 12, 14) Scheme 4 employed are replaced by 4-fluorophenyl residues gave consistently the best results (entry 2) (see also the previous and the following sections of this paper). This finding confirms the conclusion reached in an independent investigation that the electrophilicity at Mo is a key parameter for adjusting the reactivity of complexes of the general type Mo[N(tBu)(Ar)] 3 . 27 Schrock's tungsten catalyst (tBuO) 3 WtCCMe 3 15 also turned out to be compatible with the sensitive functional group pattern of substrate 19 (entry 3). Particularly noteworthy is the fact that the ketone groups in 19 and product 20 formed thereof are at least kinetically inert toward this alkylidyne complex, although closely related species are known to react rapidly with various carbonyl derivatives. 19 Unfortunately, however, the conversion of 19 into 20 did not go to completion even on prolonged reaction time employing high catalyst loadings. Difficulties in separating the product from traces of unreacted diyne 19 (4% have been recovered by flash chromatography) account for the somewhat lower yield (65%) obtained with this otherwise quite efficient catalyst.
In contrast to these successful initators, the"in situ" catalyst system employing Mo(CO) 6 and phenol additives is totally unsuitable for applications to the prostaglandin series (entry 4). Although this method deserves attention for its user-friendly setup, 16 the vigorous conditions required (130°C in chlorobenzene) preclude applications to elaborate and sensitive starting materials such as 19. Therefore it must be concluded that the scope of this "instant method" is likely restricted to rather robust cases. 12, 31 Crystals of compound 22 suitable for X-ray analysis have been obtained. This structure (Figure 1 ) is the first example of a prostaglandin lactone to be described. 32 Its 4-hydroxycyclopentanone ring adopts an envelope conformation and an alltrans alkyl chain extends from the equatorial position of C9 to the methyl terminus of C1. It is noteworthy that the ester group is perpendicular to the main ring plane of the 13-membered macrocycle. The torsion angles adjacent to the Z-alkene entity C15-C16 are 80°and 98°, respectively, forcing the alkyl chains to opposite faces of the double bond plane. For further details see the Supporting Information.
Prostaglandin Lactone Analogues. The recent cloning of several PG receptor subtypes 33 has evoked considerably renewed interest toward the development of subtype specific PG derivatives with improved phamacological indices. 34, 35 It is well established that the substitution pattern and stereochemical display around the cyclopentane ring and, in particular, the constitution of the side chains exert subtle effects on the PG receptor affinity and specificity. 1 Although prostaglandins in general mediate a host of responses and some derivatives have been successfully marketed as drugs for various clinical applications, 1 much effort has recently centered on the identification of PG derivatives relieving interocular pressure as caused by glaucoma. 36 In principle, "three-component coupling" as a triply convergent method allows substantial alterations of all segments of a PG. 21 In practice, however, variations of the R-chain are known to be problematic. Difficulties arise from undesirable equilibrations and -alkoxide elimination if the intermediate enolates such as 10 must be trapped with poorly electrophilic R-chain equivalents, some of which are rather unstable under reaction conditions and must be used in fairly large excess. The inherent flexibility of our approach may help to overcome this limitation. In this particular case, the electrophile used for the three-component assembly process is the cheap and readily available propargyl iodide 11 24 which shows excellent reactivity. We reasoned that product 13 thus obtained can be used as a common platform for the synthesis of PG analogues simply by esterification of the 15-OH group with various alkynoic acids. Ring closure of the resulting diynes then installs a modified R side chain; subsequent enzyme-mediated hydrolysis of the lactones gives access to the free hydroxy acids, if desirable. Furthermore, if PG-lactones are to be used as intramolecular prodrugs enabling sustained release in the body, modifications of the ester group and the size of the macrolactone ring should allow a fine-tuning of the hydrolysis rate and hence the bioavailability of the active component. 4 To prove the viability of this concept, we have prepared two PG-lactone analogues in addition to 15-epi-PGE 2 -1,15-lactone 22 and the acetylenic congeners 18 and 23, respectively. Thus, esterification of alcohol 13 with 9-undecynoic acid in the presence of i PrNdCdN i Pr and DMAP catalyst delivers diyne 24 which cyclizes to afford cycloalkyne 25. Lindlar hydrogenation of its triple bond followed by deprotection under standard conditions affords the ring-expanded lactone 27 in excellent overall yield (Scheme 6). Similarly, esterification of 13 with the benzoic acid derivative 28, subsequent cyclization of diyne 29 by alkyne metathesis, and elaboration of the resulting cycloalkyne 30 as described above readily provide the aromatic ester analogue 32 (Scheme 7). In both cases, the crucial ring closure has been carried out with the optimized molybdenum amido catalyst formed in situ from complex Mo[N(tBu)-(C 6 H 4 F)] 3 6 and CH 2 Cl 2 in toluene at 80°C.
It was possible to obtain crystals of 32 suitable for X-ray analysis (Figure 2) . The molecular conformation of this 16-membered macrocyclic lactone is characterized by a planar (rms deviation 0.04 Å) moiety extending from the 1,2-substituted benzo ring to C18 on one side and to the tertiary carbon (C6) on the other. The remaining portion of the ring can also be approximated by a plane (rms 0.34 Å), forming an angle of 157°with the former. The conformation of this part of the macrocycle is governed by the geometry of the annulated 4-hydroxycyclopentan-1-one ring, which adopts an envelope conformation with C9 forming the flap. The alkyl chain between C9 and C6 extending from an equatorial position of C9 includes the E double bond C7-C8 and is all-trans. The other alkyl chain between C13 and C18 contains the Z-alkene which is embedded into the macrocycle with the adjacent torsion angles (C13-C14-C15-C16 and C15-C16-C17-C18) of 125°and -141°, respectively. A final gauche conformation C18-C19 completes the macrocycle. The pentyl chain (all-trans except for the Scheme 6 Figure 2 . ORTEP diagram of the molecular structure of compound 32. Anisotropic replacement parameter ellipsoids are drawn at 50% probability; hydrogen atoms are omitted for clarity.
Scheme 7
terminating gauche conformation) points to the exo-face of the macrocycle. For further details see the Supporting Information.
Alkyne Cross Metathesis (ACM). Synthesis of (-)-PGE 2 and Further Prostaglandin Analogues. Compound 12, readily available by an efficient three-component coupling reaction as described above, opens yet another possibility to prepare intact prostaglandins via alkyne cross metathesis (ACM). This type of transformation has received very little attention so far and was essentially confined to the preparation of simple acetylenic derivatives by means of the rather forcing Mo(CO) 6 /phenol methodology. 16c,d To the best of our knowledge, no application of ACM to the synthesis of natural products has been reported to date.
As can be seen from Scheme 8, the recently introduced catalyst system Mo[N(t-Bu)(Ar)] 3 5/CH 2 Cl 2 13 is very well suited for this type of application as well. Specifically, reaction of compound 12 bearing a butynyl entity as a handle for the construction of an intact R-chain with a slight excess of the symmetrical alkyne 33 in the presence of complex 5 and CH 2 -Cl 2 as the activating agent provides the desired cross metathesis product 34 in 51% isolated yield. No trace of the homodimer of 12 has been detected. The Lindlar reduction and subsequent cleavage of the silyl protecting groups with aqueous HF in THF proceed without incident, delivering PGE 2 -methyl ester 36 in excellent yield. This compound is an established precursor for the parent hydroxy acid 4. 1, 21 To demonstrate the versatility of this approach even further, we have prepared a small series of PG analogues differing from the natural products in both side chains. Thus, reaction of n-BuLi with Me 2 Zn and 1,4-addition of the resulting zincate 38 to cyclopentenone 9 followed by interception of the resulting enolate with propargyl iodide 11 delivers product 37 in 73% yield. Subsequent cross metathesis of this "truncated" prostanoid with variously substituted internal alkynes catalyzed by 5/CH 2 Cl 2 in toluene at 80°C affords PG analogues 38-41 in respectable yields (Table 2) . Again, homodimerization of 37 does not interfere. These examples further illustrate the excellent chemoselectivity of the catalyst which is fully compatible with the alkyl chloride, acetal, nitrile, ester, ketone, and silyl ether functions in the reaction partners.
Conclusions
Two novel concepts for the formation of natural and unnatural prostaglandins have been described. The first one is based upon a ring-closing alkyne metathesis reaction of suitable diyne precursors, providing ready access to prostaglandin lactones. These unusual natural products are the only "stock form" for prostaglandins found in nature so far; they deserve attention on their own right for their interesting biological properties and constitute potential prodrugs for pharmaceutical applications. The other approach makes strategic use of alkyne cross metathesis (ACM) and represents the first application of this type of transformation to natural product synthesis. Since both entries into PG's are inherently flexible and allow systematic structural variations of the products, they may become useful tools for lead optimization in a medicinal chemistry context.
The fact that alkyne metathesis allows the high-yielding formation of very sensitive prostaglandin derivatives clearly attests to the exceptional mildness of this emerging methodology. 11-14 Furthermore, the (cyclo)alkynes thus obtained provide a convenient solution for the yet unsolved problem of conventional RCM regarding the formation of stereodefined (cyclo)alkene products. The catalysts for alkyne metathesis presently available, in particular the electronically tunable one formed in situ from Mo[N(tBu)(Ar)] 3 and CH 2 Cl 2 , 13 are not only efficient in terms of yield and reaction rate, but exhibit a remarkable selectivity pattern which qualifies them beyond doubt for even more demanding applications. To facilitate retrosynthetic planning, Table 3 compiles those functional groups that are presently known to be compatible with these novel tools. Further applications of alkyne metathesis as well as studies of the biological properties of some products described in this paper are underway and will be disclosed soon.
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